Management of Neonatal Diabetes due to a KCNJ11 Mutation with Automated Insulin Delivery System and Remote Patient Monitoring

Autor: Ming Yeh Lee, Anna L. Gloyn, David M. Maahs, Priya Prahalad

Publikováno v: Case Reports in Endocrinology, Vol 2023 (2023)

Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes. Management of hyperglycemia in neonates with subcutaneous insulin is challenging because of frequent feeding, variable quantity of milk intake with each feed, low insulin dose requirem

Externí odkaz: https://doaj.org/article/98caa4fdde7149ffba6909e0840a4fbd

Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action

Autor: Ming Yeh Lee, Molly L. Tanenbaum, David M. Maahs, Priya Prahalad

Publikováno v: Case Reports in Endocrinology, Vol 2022 (2022)

Advancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is

Externí odkaz: https://doaj.org/article/9cddc14bad3b4f28a6b91169404cf5ec

Population-level management of Type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health

Autor: Dianelys P. Morales, Ming Yeh Lee, Johannes O. Ferstad, David M. Maahs, Christos Vasilakis, Ramesh Johari, Priya Prahalad, Esli Osmanlliu, Jacqueline Vallon, Anastasiya Vitko, Brianna Leverenz, Daniel Jun, David Scheinker, Jeannine Leverenz, Angela Gu

Publikováno v: Ferstad, J, Vallon, J, Jun, D, Gu, A, Vitko, A, Morales, D, Leverenz, J, Lee, M Y, Leverenz, B, Vasilakis, C, Osmanlliu, E, Prahalad, P, Maahs, D, Johari, R & Scheinker, D 2021 ' Population-level management of Type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health ' medRxiv . https://doi.org/10.1101/2021.05.04.21256647
Pediatr Diabetes
Ferstad, J, Vallon, J, Jun, D, Gu, A, Vitko, A, Morales, D, Leverenz, J, Lee, M Y, Leverenz, B, Vasilakis, C, Osmanlliu, E, Prahalad, P, Maahs, D, Johari, R & Scheinker, D 2021, ' Population-level management of Type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health ', Pediatric Diabetes, vol. 22, no. 7, pp. 982-991 . https://doi.org/10.1111/pedi.13256

Objective To develop and scale algorithm-enabled patient prioritization to improve population-level management of type 1 diabetes (T1D) in a pediatric clinic with fixed resources, using telemedicine and remote monitoring of patients via continuous gl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6793d523f71884fe3917f2674f5d89cb
https://purehost.bath.ac.uk/ws/files/226802638/Ferstad_et_al_2021_medRxiv.pdf

Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice (Preprint)

Autor: David Scheinker, Angela Gu, Joshua Grossman, Andrew Ward, Oseas Ayerdi, Daniel Miller, Jeannine Leverenz, Korey Hood, Ming Yeh Lee, David M Maahs, Priya Prahalad

BACKGROUND The use of continuous glucose monitors (CGMs) is recommended as the standard of care by the American Diabetes Association for individuals with type 1 diabetes (T1D). Few hardware-agnostic, open-source, whole-population tools are available

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac59e3e98e4417655d035e1b74a9de91
https://doi.org/10.2196/preprints.27284

1281-P: Pilot Study on the Feasibility of Weekly CGM Data Review in Youth with New-Onset Type 1 Diabetes

Autor: Ming Yeh Lee, Jeannine Leverenz, Priya Prahalad, David M. Maahs, Natalie M. Pageler, David Scheinker, Brianna Leverenz

Publikováno v: Diabetes. 69

Despite advances in diabetes technology and treatment, many youth with type 1 diabetes (T1D) continue to have hemoglobin A1c (HbA1c) above target. Consistent use of continuous glucose monitors (CGM) improves HbA1c and time in range (TIR 70-180 mg/dl)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7e61da3906713d3fce5b3e2038c6bcd
https://doi.org/10.2337/db20-1281-p